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cardiac tissue from patients with HF (HF group: n ¼3) or with normal
left ventricular function (control group: n ¼3).
RESULTS We found that all three members of Sestrin family had
elevated expression in the early stage of cardiac hypertrophy and
decreased expression in failing hearts. Sestrin1 had a higher expres-
sion level compared to sestrin1 and sestrin2 in mouse heart. As shown
in the mouse heart, sestrin1 had the highest expression level and
dropped far below the ordinary level at the failing stage, however, the
expression of sestrin2 had no signiﬁcantly difference between normal
and failing human heart, while the sestrin 3 in HF group was more
than 2 fold increased compare to the normal group.
CONCLUSIONS Sestrin isoform had high expression in hearts espe-
cially sestrin1, and presented in a process of dynamic change during
the development and transition of cardiac hypertrophy to heart
failure. The expression proﬁle in human hearts was different from
that in the mouse heart. Further investigation of Sestrin function
and regulation may provide new insights in hypertrophic and failing
heart.
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OBJECTIVES Coptis Chinensis, a Chinese herbal medicine, has been
widely used in traditional Chinese medicine for a long time.
Berberine, the main alkaloid of Coptis Chinensis, has been recently
shown to possess extensive cardiovascular pharmacological activities.
In present study, we examined the effects of Berberine on aortic
atherosclerosis in Apolipoprotein E gene knockout mice (ApoE-/-) and
explored the potential underlying mechanisms.
METHODS 30 ApoE-/- mice, fed a high fat diet from 6 weeks of age,
were randomized into three groups (n¼10): model group (ApoE-/-
gourp), Berbrine group (ApoE-/-þBerbrine group) and Simvastatin
group (ApoE-/-þSimvastatin group). 10 6-week-old C57BL/6 were
treated as the control group, fed a basic diet. After 36 weeks, we
sacriﬁced the mice for various measurements with ELISA, Western
blot and Real-time PCR.
RESULTS The results showed that treatment with Berberine signiﬁ-
cantly reduced blood lipid. Berbrine has the effect of anti-proliferation
of Smooth Muscle Cells. It could reduce the level of Hs-CRP, IL-6 and
TNF-a in plasma. And it could reduce protein and mRNA expression of
NF-kB and MMP-9 in aorta. There is no signiﬁcant difference between
the effects of Berberine and Simvastatin group.
CONCLUSIONS Berberine has the effect of anti-atherosclerosis and
anti-inﬂammation in ApoE-/- mice. Our data have provided some
experimental evidences to use Berberine in prevention and cure of
atherosclerosis.
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OBJECTIVES Explore the (resulting in myocarditis) cross-protective
immunity coxsackievirus B3 gene vaccine for other types of Coxsackie
virus infection.
METHODS Using molecular biological method, Competence bacte-
rium were produced and transformed by pcDNA3CVB3VP1 recombi-
nant plasmid.the recombinant plasmids were extracted a little and
identiﬁed by sect-enzyme, PCR and sequence; the accredited gene
vaccine were Proliferated abundantly and BALb/c mice were
immuned then. After 4 weeks and 6 weeks, immunization serum was
acquired. CVB1, CVB3, CVB3m and CVB5 were Proliferated and titrated
by virological experimental method;cross-immunization protection
were observed by Neutralization test.
RESULTS After pcDNA3CVB3VP1 gene vaccine were identiﬁed, it was
showed that aimed CVB3VP1 fragment were conjuncted with plasmid
pcDNA3; results of neutralization tests indicate that pathological
changes of Hela cells infected by CVB1, CVB3, CVB3m and CVB5 were
attenuated due to adding serum from mice bodies inoculated withcoxsackievirus B3. Moreover attenuating degree of pathological
changes of Hela cells was different which were infected by different
types of viruses.
CONCLUSIONS Coxsackievirus B3 gene vaccine plays a protective
role in infection of CVB1, CVBV3, CVB3m and CVB5.furthermore
the protection is different in infection of CVB1, CVB3, CVB3m and
CVB5.
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OBJECTIVES Monocyte recruitment in arterial wall is an early event
in atherogenesis. The classically activated macrophages (M1 subpop-
ulation) and alternative-activated macrophage (M2 subpopulation)
can arise from monocytes in response to different stimuli. In this
study, we tried to evaluate the susceptibility to M1 and M2 activation
of monocytes circulating in the blood of healthy individuals and pa-
tients with asymptomatic carotid atherosclerosis.
METHODS Cross-sectional clinical study was performed, which
involved healthy donors, apparently healthy subjects with a predis-
position to atherosclerosis, and patients with subclinical atheroscle-
rosis. Study participants did not have clinical manifestations of
atherosclerotic disease (ischemic heart disease, myocardial infarction,
stroke history), did not take cardiotropic and lipid-lowering drugs,
and did not have concurrent chronic diseases that may affect the re-
sults of the study (diabetes mellitus, oncopathology, collagenoses,
asthma, endocrine diseases). Quantitative diagnostics of pre-athero-
sclerotic and atherosclerotic states was performed by high-resolution
ultrasonography of carotid arteries followed my intima-media thick-
ness (IMT) of common carotid arteries. To identify individual proﬁles
of cell activation, monocytes were isolated from whole blood using
magnetic CD14-positive separation. Functional analysis of monocyte
activity included the measurement of concentrations of cytokines
produced by cells under standardized conditions in response to
pro-inﬂammatory stimulation with interferon-gamma or anti-inﬂam-
matory stimulation with interleukin-4. Secretion of TNF-a was
considered to be a marker of pro-inﬂammatory activity of macro-
phages, while secretion of CCL18 chemokine as a marker of anti-
inﬂammatory activity. Concentrations of TNF-a and CCL18 in the
culture medium were determined by ELISA on day 1 or 6 after cell
isolation, respectively.
RESULTS Surprisingly, we found a dramatic individual difference in
susceptibility to activation between monocytes isolated from the
blood of different subjects, regardless of the presence or absence of
atherosclerosis. Monocytes in early atherosclerotic lesions may
migrate back into the circulation, possibly serving as a lipid clearance
system. We attempted to ﬁnd the relationship between cholesterol in
monocytes and their susceptibility to activation. There was an
obvious trend towards a reverse association between intracellular
cholesterol level and the ability of monocytes to become activated;
however, correlation coefﬁcients did not reach statistical signiﬁcance.
To reveal the reason of relationship between intracellular cholesterol
level and monocyte susceptibility to activation, we used atherogenic
modiﬁed LDL from patients with documented atherosclerosis to
induce cholesterol accumulation in cultured cells. Although modiﬁed
LDL induced cholesterol accumulation in cultured monocyte-derived
cells neither cytokine secretion nor cytokine genes expression were
affected.
CONCLUSIONS We believe these observations are very important
because the identiﬁed differences may explain the individual features
of the immune response in different subjects.
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OBJECTIVES Endothelial cell (EC) dysfunction is a key event in the
onset and progression of atherosclerosis. Our previous studies showed
